Heike Brotz-oesterhelt

Prof. Dr. rer. nat. Heike Brötz-Oesterhelt studied Biology in Bonn, Germany, and obtained her Diploma and PhD degrees in Microbiology. For more than 20 years she has been working in antibacterial drug discovery in the academic as well as in the pharmaceutical industry setting. After her PhD she joined the Anti-Infectives Department of Bayer HealthCare in Wuppertal, evaluating novel targets and developing lead structures. She headed project teams in structure optimization campaigns and coordinated all early research activities of the department.
After 8 years in “big pharma”, she co-founded the Biotech company AiCuris. In 2010 she returned to academia as a professor for Pharmaceutical Biology at the University of Duesseldorf and since 2014 she is full professor for Microbiology at the University of Tubingen heading the Department of Microbial Bioactive Compounds. She is particularly interested in molecular mechanisms of new antibiotic lead structures and operation modes of novel antibiotic targets.